Glioblastoma: open trials in Japan

2 open trials have a site in Japan. Registry data; only the trial team decides who can take part.

NCT06641908
Anti-GD2 ADC M3554 in Advanced Solid Tumors
Trial Treatment · Phase 1 · EMD Serono Research & Development Institute, Inc.
National Cancer Center Hospital, Chūōku
Registry updated 2026-11-05
NCT06914128
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
Trial Treatment · Phase 1/2 · Bayer
National Cancer Center Hospital, Chuo Ku · National Cancer Center Hospital East, Kashiwa · The Cancer Institute Hospital of JFCR, Koto-ku · Nagoya University Hospital, Nagoya · Kindai University Hospital, Sakai · Shizuoka Cancer Center, Sunto
Registry updated 2026-10-28

This page is not medical advice. Talk to your doctor before contacting a trial.

Anti-GD2 ADC M3554 in Advanced Solid Tumors